Technical Articles
Siglec-2/CD22
Application of FITC-labeled Siglec-2/CD22 Fc chimeric protein in B-cell immunotherapy research
CD22, also known as Siglec-2, is a key member of the sialic acid-binding immunoglobulin-like lectin family, belonging to type I transmembrane proteins with a molecular weight of 140 kDa.
View details
- Immunity/Inflamma
- Siglec-2/CD22
- B Cells
- Immunotherapy
How Siglec-2/CD22 Is Rewriting the Therapeutic Landscape of B-Cell Malignancies
This article describes the mechanism of action of Siglec-2/CD22, expounds the expression roles of Siglec-2/CD22 in the development, activation, and functional regulation of B cells, and illustrates their importance.
View details
- Cancer
- Siglec-2/CD22
- B cells
- 1













